Reconstructing tumor clonal lineage trees incorporating single-nucleotide variants, copy number alterations and structural variations

Bioinformatics. 2022 Jun 24;38(Suppl 1):i125-i133. doi: 10.1093/bioinformatics/btac253.

Abstract

Motivation: Cancer develops through a process of clonal evolution in which an initially healthy cell gives rise to progeny gradually differentiating through the accumulation of genetic and epigenetic mutations. These mutations can take various forms, including single-nucleotide variants (SNVs), copy number alterations (CNAs) or structural variations (SVs), with each variant type providing complementary insights into tumor evolution as well as offering distinct challenges to phylogenetic inference.

Results: In this work, we develop a tumor phylogeny method, TUSV-ext, which incorporates SNVs, CNAs and SVs into a single inference framework. We demonstrate on simulated data that the method produces accurate tree inferences in the presence of all three variant types. We further demonstrate the method through application to real prostate tumor data, showing how our approach to coordinated phylogeny inference and clonal construction with all three variant types can reveal a more complicated clonal structure than is suggested by prior work, consistent with extensive polyclonal seeding or migration.

Availability and implementation: https://github.com/CMUSchwartzLab/TUSV-ext.

Supplementary information: Supplementary data are available at Bioinformatics online.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Algorithms
  • Clonal Evolution
  • DNA Copy Number Variations*
  • Humans
  • Neoplasms* / genetics
  • Nucleotides
  • Phylogeny
  • Software

Substances

  • Nucleotides